BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.

Saved in:
Bibliographic Details
Title: BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
Authors: Pérez-Galán, P.1, Roué, G.1, López-Guerra, M.1, Nguyen, M.2, Villamor, N.1, Montserrat, E.1, Shore, G. C.2,3, Campo, E.1, Colomer, D.1 dcolomer@clinic.ub.es
Source: Leukemia (08876924). Sep2008, Vol. 22 Issue 9, p1712-1720. 9p. 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/leu.2008.175